Columbia Herbert Irving Cancer Center – Gestational Trophoblastic Disease Program is a specialized cancer treatment center located in New York, New York. This program focuses on the diagnosis and management of gestational trophoblastic disease, a rare group of pregnancy-related tumors. Situated within the renowned Herbert Irving Comprehensive Cancer Center, it combines expertise from the Division of Gynecologic Oncology at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Hospital to offer comprehensive care for patients facing this complex condition.
The center emphasizes a multidisciplinary approach, integrating advanced diagnostic techniques and personalized treatment plans tailored to each patient’s unique medical needs. Specialists at the facility work collaboratively to provide a continuum of care that spans from initial diagnosis through treatment and follow-up monitoring. Their commitment to detailed clinical assessment and innovative therapeutic options reflects a deep understanding of gestational trophoblastic disease and its impact on women’s health.
Located at 161 Fort Washington Avenue, the cancer treatment center is equipped with state-of-the-art medical technology and resources designed to support both patients and their families throughout the treatment journey. The program also facilitates access to clinical research opportunities and cutting-edge therapies, ensuring that care is aligned with the latest developments in oncology. Patients seeking specialized treatment for gestational trophoblastic disease in New York benefit from the center’s focused expertise and collaborative medical environment.
